文献速递乳房整形与再造显微修复重建

静脉血栓栓塞史患者行显微自体乳房再造的安全性:14,309例回顾性队列研究

Is microsurgical autologous breast reconstruction safe in patients with a history of venous thromboembolism? A retrospective cohort study of 14,309 patients.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2026-08-07

基于TriNetX的回顾性队列研究,比较有VTE史(395例)与无VTE史(13,914例)患者行显微自体乳房再造的术后并发症风险。结果显示有VTE史者术后90天内DVT、PE、伤口裂开、感染、疼痛、急诊就诊和住院风险显著升高,但术后2年翻修率无显著差异。

要点

  • 有VTE史患者显微自体乳房再造术后DVT风险RR 16.151(P<0.0001)。
  • 有VTE史患者术后PE风险RR 15.828(P<0.0001)。
  • 术后2年翻修率两组无显著差异。

核心结论

  • 有VTE史患者行显微自体乳房再造术后DVT、PE、感染、伤口裂开、疼痛、急诊就诊和住院风险显著升高。
  • 术后2年翻修率无显著差异。

研究设计与样本

  • 回顾性队列研究,使用TriNetX数据库。
  • 暴露组为有VTE史患者(395例),对照组为无VTE史患者(13,914例),均行显微自体乳房再造。
  • 主要结局为术后DVT和PE发生率,次要结局包括感染、伤口裂开、出血、疼痛、急诊就诊、住院和翻修。
  • 结局评估时间为术后30、60、90天,翻修评估至术后2年。

主要发现

  • 术后90天,有VTE史患者DVT风险显著更高(RR 16.151,P<0.0001)。
  • 术后90天,有VTE史患者PE风险显著更高(RR 15.828,P<0.0001)。
  • 术后90天,有VTE史患者伤口裂开风险显著更高(RR 1.354,P=0.0436)。
  • 术后90天,有VTE史患者感染风险显著更高(RR 1.697,P=0.0004)。
  • 术后90天,有VTE史患者疼痛(RR 1.667,P<0.0001)、急诊就诊(RR 2.236,P<0.0001)和住院(RR 1.336,P<0.0001)风险显著更高。

临床怎么用

  • 对有VTE史患者行显微自体乳房再造术前应充分评估血栓风险并加强围手术期预防。
  • 术后90天内需密切监测DVT、PE、感染、伤口裂开等并发症。

局限性

  • 本研究为未调整分析,可能存在混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Venous thromboembolism (VTE) may suggest underlying hypercoagulable state. As much as thrombotic or thromboembolic events can jeopardize flap surgeries, relatively little is known about the associated postoperative complication risks in microsurgical autologous breast reconstruction (ABR). METHODS: To investigate postoperative complication risks of microsurgical ABR in patients with a history of VTE, we conducted a retrospective cohort study using TriNetX. Of patients who underwent microsurgical ABR, those with prior VTE comprised the exposure cohort; those without comprised the control cohort. Primary outcomes were postoperative rates of deep vein thrombosis (DVT) and pulmonary embolism (PE). Secondary outcomes were postoperative rates of infection, wound dehiscence, bleeding, pain, emergency department (ED) visits, hospitalizations, and revisions. Outcomes were assessed at postoperative days 30, 60, and 90, except revisions, which were assessed at postoperative year 2. RESULTS: There were 395 and 13,914 patients in the exposure and control cohorts, respectively. At postoperative day 90, patients with prior VTE were at significantly higher risks of postoperative DVT (risk ratio [RR] 16.151, P-value [P] < 0.0001), PE (RR 15.828, P < 0.0001), wound dehiscence (RR 1.354, P = 0.0436), infection (1.697, P = 0.0004), pain (RR 1.667, P < 0.0001), ED visits (RR 2.236, P < 0.0001), and hospitalizations (RR 1.336, P < 0.0001). At postoperative year 2, revision rates were not significantly different. CONCLUSION: In this unadjusted analysis, patients undergoing microsurgical ABR with a prior history of VTE were at significantly higher risks of postoperative DVT, PE, infection, wound dehiscence, pain, ED visits, and hospitalizations.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Lee S, Thomas C, Posso AN, et al. Is microsurgical autologous breast reconstruction safe in patients with a history of venous thromboembolism? A retrospective cohort study of 14,309 patients. J Plast Reconstr Aesthet Surg. 2026. PMID: 42600541. doi:10.1016/j.bjps.2026.08.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。